(Q33363031)

English

Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma

scientific article

Statements

Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphoma (English)
Hemachandra Venkatesh
Nicholas Di Bella
Thomas P Flynn
Mark J Vellek
Kristi A Boehm
1 September 2004

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit